SQUAWK/NEWS
Account
Account
Menu
Live News REGULATION FLASH L impact

Castle Biosciences approved for dual listing on Nasdaq Texas

Castle Biosciences (CSTL) received approval for a dual listing on Nasdaq Texas,

CSTL

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.